Chemical Proteomic Approach for In-Depth Glycosylation Profiling of Plasma Carcinoembryonic Antigen in Cancer Patients
Molecular & Cellular Proteomics · 2023-11 · 22 (11) · 100662
DOI: 10.1016/j.mcpro.2023.100662 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2023-11. Verfasst von Jin Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Research Center for Chemical Biology and Omics Analysis, School of Science, Southern University of Science and Technology…. Hauptthemen laut MEDLINE: Carcinoembryonic Antigen, Lung Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science, Technology and Innovation Commission of Shenzhen Municipality, Natural Science Foundation of Fujian Province, Government of Guangdong Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Carcinoembryonic antigen (CEA) of human plasma is a biomarker of many cancer diseases, and its N-glycosylation accounts for 60% of molecular mass. It is highly desirable to characterize its glycoforms for providing additional dimension of features to increase its performance in prognosis and diagnosis of cancers. However, to systematically characterize its site-specific glycosylation is challenging because of its low abundance. Here, we developed a highly sensitive strategy for in-depth glycosylation profiling of plasma CEA through chemical proteomics combined with multienzymatic digestion. A trifunctional probe was utilized to generate covalent bond of plasma CEA and its antibody upon UV irradiation. As low as 1 ng/ml CEA in plasma could be captured and digested with trypsin and chymotrypsin for intact glycopeptide characterization. Twenty six of 28 potential N-glycosylation sites were well identified, which were the most comprehensive N-glycosylation site characterization of CEA on intact glycopeptide level as far as we known. Importantly, this strategy was applied to the glycosylation analysis of plasma CEA in cancer patients. Differential site-specific glycoforms of plasma CEA were observed in patients with colorectal cancers (CRCs) and lung cancer. The distributions of site-specific glycoforms were different as the progression of CRC, and most site-specific glycoforms were overexpressed in stage II of CRC. Overall, we established a highly sensitive chemical proteomic method to profile site-specific glycosylation of plasma CEA, which should generally applicable to other well-established cancer glycoprotein biomarkers for improving their cancer diagnosis and monitoring performance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Research Center for Chemical Biology and Omics Analysis, School of Science, Southern University of Science and Technology, Shenzhen, China; Clinical Center for Molecular Diagnosis and Therapy…
- Department of Oncology, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, China; The First Affiliated Hospital, Jinan University, Guangzhou, China.
- Department of Chemistry and Research Center for Chemical Biology and Omics Analysis, School of Science, Southern University of Science and Technology, Shenzhen, China.
- Department of Oncology, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, China.
- Department of Oncology, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen, China. Electronic address: xuruilian@126.com.
- Department of Chemistry and Research Center for Chemical Biology and Omics Analysis, School of Science, Southern University of Science and Technology, Shenzhen, China. Electronic address: tianrj@sustech.edu.cn.
Förderung
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Natural Science Foundation of Fujian Province
- Government of Guangdong Province
- Southern University of Science and Technology
- National Natural Science Foundation of China
Zitieren
APA
Chen, J., Yang, L., Li, C., Zhang, L., Gao, W., Xu, R., & Tian, R. (2023). Chemical Proteomic Approach for In-Depth Glycosylation Profiling of Plasma Carcinoembryonic Antigen in Cancer Patients. Molecular & Cellular Proteomics, 22(11), 100662. https://doi.org/10.1016/j.mcpro.2023.100662
Vancouver
Chen J, Yang L, Li C, Zhang L, Gao W, Xu R, et al. Chemical Proteomic Approach for In-Depth Glycosylation Profiling of Plasma Carcinoembryonic Antigen in Cancer Patients. Molecular & Cellular Proteomics. 2023;22(11):100662. doi:10.1016/j.mcpro.2023.100662
BibTeX
@article{Chen2023,
author = {Chen, Jin and Yang, Lijun and Li, Chang and Zhang, Luobin and Gao, Weina and Xu, Ruilian and Tian, Ruijun},
title = {Chemical Proteomic Approach for In-Depth Glycosylation Profiling of Plasma Carcinoembryonic Antigen in Cancer Patients},
journal = {Molecular & Cellular Proteomics},
year = {2023},
volume = {22},
number = {11},
pages = {100662},
doi = {10.1016/j.mcpro.2023.100662}
}
EUVIMED